GRI

GRI Bio, Inc. GRI

GRI
GRI Bio, Inc. WINT
Windtree Therapeutics, Inc. JAGX
Jaguar Health, Inc. CLDI
Calidi Biotherapeutics, Inc. SILO
Silo Pharma, Inc. CNSP
CNS Pharmaceuticals, Inc. OCEA
Ocean Biomedical, Inc. INM
InMed Pharmaceuticals Inc. LEXX
Lexaria Bioscience Corp. CANF
Can-Fite BioPharma Ltd.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode GRI WINT JAGX CLDI SILO CNSP OCEA INM LEXX CANF
6M 27.45 % -89.20 % -61.68 % -71.24 % -41.73 % -6.10 % -98.61 % -19.85 % -40.36 % -56.10 %
YTD -86.51 % -99.28 % -92.11 % -88.67 % -36.82 % -86.84 % -99.90 % -55.42 % -63.70 % -69.83 %
1Y -75.29 % -99.65 % -93.01 % -88.76 % -48.70 % -87.50 % -99.94 % -53.07 % -70.91 % -80.00 %
3Y -99.99 % -100.00 % -99.96 % -99.86 % -88.00 % -99.99 % -99.99 % -97.93 % -59.07 % -92.63 %
5Y -100.00 % -100.00 % -99.99 % -99.86 % 71.49 % -100.00 % -99.99 % -99.88 % -81.36 % -97.03 %
10Y -100.00 % -100.00 % -100.00 % -99.86 % 71.49 % -100.00 % -99.99 % -99.90 % -81.36 % -99.91 %
Depuis le début -100.00 % -100.00 % -100.00 % -99.86 % 71.49 % -100.00 % -99.99 % -99.95 % -81.36 % -99.93 %

Dividende